← All stocks

Certara, Inc.

CERT No buying or selling

CIK 0001827090 #2340 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

17 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Feehery William F

CHIEF EXECUTIVE OFFICER

—

2,360,769

$19.59M

+5.0%

CASHMAN JAMES E III

Director

—

484,197

$4.02M

+6.1%

Aspbury Robert

PRESIDENT, PREDICTIVE TECH

—

332,442

$2.76M

+14.9%

WALSH MATTHEW M

Director

—

213,316

$1.77M

+14.9%

Pedersen Leif E

PRESIDENT, CHIEF COMMERCAL OFF

—

110,045

$913.37K

+10.4%

Gallagher John E

Chief Financial Officer

—

95,371

$791.58K

+423.5%

Killefer Nancy

Director

—

51,846

$430.32K

+114.6%

Collins Cynthia

Director

—

51,846

$430.32K

+114.6%

BROSHY ERAN

Director

—

50,708

$420.88K

+120.2%

SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

—

50,091

$415.76K

0.0%

Crane Rosemary A

Director

—

45,672

$379.08K

+153.9%

Resnick Jon Matthew

Chief Executive Officer

—

35,389

$293.73K

—

Corcoran Daniel

SVP and General Counsel

—

32,046

$265.98K

—

Reynders John V W

Chief Financial Officer

—

26,466

$219.67K

—

Anhalt Rona

Chief Human Resources Officer

—

16,789

$139.35K

—

McKemey Adrian

President, Drug Dev. Solutions

—

8,207

$68.12K

—

Bedi Arjun

Director

—

5,547

$46.04K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Certara, Inc.

By person

Individual transactions

What was left out